Microbial Restoriation in Crohn's Disease: A Randomised Trial of Faecal Microbial Transplanatation in Crohn's Disease [ 1/1/2021 - 12/31/2025 ]

Research Grant

Brief description Crohn's disease causes inflammation and damage to the digestive tract. Compelling evidence suggests that the bacteria in the gut play an important role in the onset of disease. Changing the gut bacteria through the administration of healthy stool to a patient, faecal microbiota transplantation (FMT), is safe and may be effective. This placebo controlled trial will determine whether FMT (delivered via capsule) can control inflammation in Crohn's. Results will change current treatment paradigms.

Funding Amount $487,123

Funding Scheme Investigator Grants

Chief Investigator Dr Emily Wright

Notes Emerging Leadership 1